EE396 Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System
Abstract
Authors
PEDRO C. AGOSTINHO Beatriz Borba Carlos Alberto Rangel NAIANE COSTA